<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.0 Transitional//EN" "http://www.w3.org/TR/REC-html40/loose.dtd">
<html><body><html><body><section class="summaryOfFindings"><div class="section-header section-collapse-header" id="CD009434-sec-0008" lang="en"> <h2 class="title section-collapse-title"> Summary of findings <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="summaryOfFindings" lang="en"><div class="section-header" id="CD009434-sec-0008"></div> <div class="table" id="CD009434-tbl-0001"> <a href="#0" class="open-table-viewer open-in-figure-viewer">Open in table viewer</a><div class="table-heading">
<span class="table-label">Summary of findings 1.</span> <span class="table-title">Laser compared to placebo/no treatment for patients with dentinal hypersensitivity tested via VAS with the value range from 0 to 10 (no pain to worst possible pain) in response to air blast stimuli</span>
</div>
<table class="summary-of-findings framed">
<tbody>
<tr class="separated">
<th scope="col" align="left" valign="top" colspan="6" rowspan="1" class="headercell"> <p><b>Laser compared to placebo/no treatment for patients with dentinal hypersensitivity tested via VAS with the value range from 0 to 10 (no pain to worst possible pain) in response to air blast stimuli</b> </p> </th> </tr>
<tr class="separated">
<td align="left" valign="top" colspan="6" rowspan="1" bgcolor="#ffffff"> <p><b>Patient or population:</b> patients with dentinal hypersensitivity<br><b>Setting:</b> dental clinic<br><b>Intervention:</b> laser<br><b>Comparison:</b> placebo/no treatment </p> </td> </tr>
<tr class="separated">
<th scope="col" align="left" valign="top" colspan="1" rowspan="2" class="headercell"> <p><b>Outcomes</b> </p> </th> <th scope="col" align="left" valign="top" colspan="2" rowspan="1" class="headercell table-tint"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </th> <th scope="col" align="left" valign="top" colspan="1" rowspan="2" class="headercell"> <p><b>Number of teeth<br>(studies)</b> </p> </th> <th scope="col" align="left" valign="top" colspan="1" rowspan="2" class="headercell"> <p><b>Certainty of the evidence<br>(GRADE)</b> </p> </th> <th scope="col" align="left" valign="top" colspan="1" rowspan="2" class="headercell"> <p><b>Comments</b> </p> </th> </tr>
<tr class="separated">
<th scope="col" align="left" valign="top" colspan="1" rowspan="1" class="headercell table-tint"> <p><b>Risk with placebo/no treatment</b> </p> </th> <th scope="col" align="left" valign="top" colspan="1" rowspan="1" class="headercell table-tint"> <p><b>Risk with laser</b> </p> </th> </tr>
<tr class="separated">
<td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Changes in intensity of pain (VAS with the value range from 0 to 10 (no pain to worst possible pain)) when tested through air blast stimuli ‐ short term (0 to 24 hours)<br>All types of laser </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>The mean changes in pain intensity ranged from 0.10 to 4.80</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>MD 2.24 lower<br>(3.55 lower to 0.93 lower) </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>978<br>(13 RCTs) </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>⊕⊕⊝⊝<br>LOW<sup>a</sup></p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Lasers may reduce pain intensity in the short term when compared to placebo/no treatment. Pain reduction was observed in the lasers group in the short term with a mean VAS score difference of 2.22 suggesting minimal clinical significance. The effective lasers in this category were Er,Cr:YSGG, diode (630 nm to 700 nm), and diode (850 nm to 980 nm) </p> </td> </tr>
<tr class="separated">
<td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Changes in intensity of pain (VAS with the value range from 0 to 10 (no pain to worst possible pain)) when tested through air blast stimuli ‐ medium term (24 hours to 2 months)<br>All types of laser </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>The mean changes in pain intensity ranged from 0.10 to 5.18</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>MD 2.46 lower<br>(3.57 lower to 1.35 lower) </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1007<br>(11 RCTs) </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>⊕⊝⊝⊝<br>VERY LOW<sup>b,c</sup></p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Lasers may reduce pain intensity in the medium term when compared to placebo/no treatment but the evidence is very uncertain. Pain reduction was observed in the lasers group in the medium term with a mean VAS score difference of 2.41 suggesting minimal clinical significance. The effective lasers in this category were Er,Cr:YSGG, diode (700 nm to 850 nm), and diode (850 nm to 980 nm) </p> </td> </tr>
<tr class="separated">
<td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Changes in intensity of pain (VAS with the value range from 0 to 10 (no pain to worst possible pain)) when tested through air blast stimuli ‐ long term (more than 2 months)<br>All types of laser </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>The mean changes in pain intensity ranged from 0.30 to 4.73</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>MD 2.60 lower<br>(4.47 lower to 0.73 lower) </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>564<br>(5 RCTs) </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>⊕⊝⊝⊝<br>VERY LOW<sup>c,d</sup></p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Lasers may reduce pain intensity in the long term when compared to placebo/no treatment but the evidence is very uncertain. Pain reduction was observed in the lasers group in the long term with a mean VAS score difference of 2.60 suggesting minimal clinical significance. The effective lasers in this category were Er,Cr:YSGG and diode (850 nm to 980 nm) </p> </td> </tr>
<tr class="separated">
<td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Adverse events</p> </td> <td align="left" valign="top" colspan="2" rowspan="1" class="table-tint table-highlight"> <p>No adverse event was noted in the experimental and control groups</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>954</p> <p>(11 RCTs)</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>⊕⊕⊝⊝<br>LOW<sup>e</sup></p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐</p> </td> </tr>
<tr class="separated">
<td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Patient‐reported quality of life</p> </td> <td align="left" valign="top" colspan="5" rowspan="1" class="table-tint table-highlight"> <p>Outcome not measured in any of the included studies</p> </td> </tr>
<tr class="separated">
<td align="" valign="" colspan="6" rowspan="1" bgcolor="#ffffff"> <p><sup>*</sup><b>The risk in the intervention group</b> (and its 95% CI) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br><br><b>CI:</b> confidence interval; <b>Er,Cr:YSGG:</b> erbium,chromium:yttrium‐scandium‐gallium‐garnet; <b>MD:</b> mean difference; <b>nm:</b> nanometer; <b>RCT:</b> randomized controlled trial; <b>VAS:</b> visual analogue scale </p> </td> </tr>
<tr class="separated">
<td align="" valign="" colspan="6" rowspan="1" bgcolor="#ffffff"> <p><b>GRADE Working Group grades of evidence</b><br><b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect<br><b>Moderate certainty:</b> we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different<br><b>Low certainty:</b> our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect<br><b>Very low certainty:</b> we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect </p> </td> </tr>
</tbody>
<tfoot><tr>
<td colspan="6"> <div class="table-footnote"> <p><sup>a</sup>Downgraded 2 levels for inconsistency: marked heterogeneity is noted among the studies (I<sup>2</sup> = 99%).<br><sup>b</sup>Downgraded 1 level for risk of bias: blinding of outcome assessors was not performed or unclear in studies that contribute significantly to the participants' pool. Blinding of participants was not performed in 1 of the parallel studies.<br><sup>c</sup>Downgraded 2 levels for inconsistency: marked heterogeneity is noted among the studies (I<sup>2</sup> = 98%).<br><sup>d</sup>Downgraded 1 level for imprecision: wide confidence interval.<br><sup>e</sup>Downgraded 1 level each for risk of bias and imprecision. </p> </div> </td> </tr></tfoot>
</table>
</div> <div class="table" id="CD009434-tbl-0002"> <a href="#0" class="open-table-viewer open-in-figure-viewer">Open in table viewer</a><div class="table-heading">
<span class="table-label">Summary of findings 2.</span> <span class="table-title">Laser compared to placebo/no treatment for patients with dentinal hypersensitivity tested via VAS with the value range from 0 to 10 (no pain to worst possible pain) in response to tactile stimuli</span>
</div>
<table class="summary-of-findings framed">
<tbody>
<tr class="separated">
<th scope="col" align="left" valign="top" colspan="6" rowspan="1" class="headercell"> <p><b>Laser compared to placebo/no treatment for patients with dentinal hypersensitivity tested via VAS with the value range from 0 to 10 (no pain to worst possible pain) in response to tactile stimuli</b> </p> </th> </tr>
<tr class="separated">
<td align="left" valign="top" colspan="6" rowspan="1" bgcolor="#ffffff"> <p><b>Patient or population:</b> patients with dentinal hypersensitivity<br><b>Setting:</b> dental clinic<br><b>Intervention:</b> laser<br><b>Comparison:</b> placebo/no treatment </p> </td> </tr>
<tr class="separated">
<th scope="col" align="left" valign="top" colspan="1" rowspan="2" class="headercell"> <p><b>Outcomes</b> </p> </th> <th scope="col" align="left" valign="top" colspan="2" rowspan="1" class="headercell table-tint"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </th> <th scope="col" align="left" valign="top" colspan="1" rowspan="2" class="headercell"> <p><b>Number of teeth<br>(studies)</b> </p> </th> <th scope="col" align="left" valign="top" colspan="1" rowspan="2" class="headercell"> <p><b>Certainty of the evidence<br>(GRADE)</b> </p> </th> <th scope="col" align="left" valign="top" colspan="1" rowspan="2" class="headercell"> <p><b>Comments</b> </p> </th> </tr>
<tr class="separated">
<th scope="col" align="left" valign="top" colspan="1" rowspan="1" class="headercell table-tint"> <p><b>Risk with placebo/no treatment</b> </p> </th> <th scope="col" align="left" valign="top" colspan="1" rowspan="1" class="headercell table-tint"> <p><b>Risk with laser</b> </p> </th> </tr>
<tr class="separated">
<td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Changes in intensity of pain (VAS with the value range from 0 to 10 (no pain to worst possible pain)) when tested through tactile stimuli ‐ short term (0 to 24 hours)<br>All types of laser </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>The mean changes in pain intensity ranged from 0.10 to 3.17</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>MD 0.67 lower<br>(1.31 lower to 0.03 lower) </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>506<br>(8 RCTs) </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>⊕⊕⊝⊝<br>LOW<sup>a,b</sup></p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Lasers may reduce pain intensity in the short term when compared to placebo/no treatment. Pain reduction was observed in the lasers group in the short term with a mean VAS score difference of 0.65 suggesting minimal clinical significance. The effective laser in this category was diode </p> </td> </tr>
<tr class="separated">
<td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Changes in intensity of pain (VAS with the value range from 0 to 10 (no pain to worst possible pain)) when tested through tactile stimuli ‐ medium term (24 hours to 2 months)<br>All types of laser </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>The mean changes in pain intensity ranged from 0.30 to 3.60</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>MD 1.73 lower<br>(3.17 lower to 0.30 lower) </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>591<br>(9 RCTs) </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>⊕⊝⊝⊝<br>VERY LOW<sup>a,c</sup></p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Lasers may reduce pain intensity in the medium term when compared to placebo/no treatment but the evidence is very uncertain. Pain reduction was observed in the lasers group in the medium term with a mean VAS score difference of 1.14 suggesting minimal clinical significance. The effective lasers in this category were GaAlAs and diode </p> </td> </tr>
<tr class="separated">
<td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Changes in intensity of pain (VAS with the value range from 0 to 10 (no pain to worst possible pain)) when tested through tactile stimuli ‐ long term (more than 2 months)<br>All types of laser </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>The mean changes in pain intensity ranged from 0.50 to 2.30</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>MD 3.52 lower<br>(10.37 lower to 3.33 higher) </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>184<br>(2 RCTs) </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>⊕⊝⊝⊝<br>VERY LOW<sup>d,e,f</sup></p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>There was insufficient evidence of a difference in pain intensity for all types of lasers in the long term </p> </td> </tr>
<tr class="separated">
<td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Adverse events</p> </td> <td align="left" valign="top" colspan="2" rowspan="1" class="table-tint table-highlight"> <p>No adverse event was noted in the experimental and control groups</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>386</p> <p>(5 RCTs)</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>⊕⊕⊝⊝<br>LOW<sup>g</sup></p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐</p> </td> </tr>
<tr class="separated">
<td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Patient‐reported quality of life</p> </td> <td align="left" valign="top" colspan="5" rowspan="1" class="table-tint table-highlight"> <p>Outcome not measured in any of the included studies</p> </td> </tr>
<tr class="separated">
<td align="" valign="" colspan="6" rowspan="1" bgcolor="#ffffff"> <p><sup>*</sup><b>The risk in the intervention group</b> (and its 95% CI) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br><br><b>CI:</b> confidence interval; <b>GaAIAs:</b> gallium‐aluminum‐arsenide; <b>MD:</b> mean difference; <b>RCT:</b> randomized controlled trial; <b>VAS:</b> visual analogue scale </p> </td> </tr>
<tr class="separated">
<td align="" valign="" colspan="6" rowspan="1" bgcolor="#ffffff"> <p><b>GRADE Working Group grades of evidence</b><br><b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect<br><b>Moderate certainty:</b> we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different<br><b>Low certainty:</b> our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect<br><b>Very low certainty:</b> we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect </p> </td> </tr>
</tbody>
<tfoot><tr>
<td colspan="6"> <div class="table-footnote"> <p><sup>a</sup>Downgraded 1 level for risk of bias: studies with significant contribution to data analysis were rated as at unclear and high risk of bias for randomization and blinding of outcome assessors.<br><sup>b</sup>Downgraded 1 level for inconsistency: marked heterogeneity with I<sup>2</sup> = 92% and some studies crossing the threshold.<br><sup>c</sup>Downgraded 2 levels for inconsistency: marked heterogeneity with I<sup>2</sup> = 97% and some studies crossing the threshold.<br><sup>d</sup>Downgraded 1 level for risk of bias: the study with significant contribution to data analysis was rated as at unclear risk of bias for selection, detection, and attrition bias.<br><sup>e</sup>Downgraded 2 levels for inconsistency: marked heterogeneity with I<sup>2</sup> = 99%.<br><sup>f</sup>Downgraded 1 level for imprecision: wide confidence interval crossing the threshold.<br><sup>g</sup>Downgraded 1 level each for risk of bias and imprecision. </p> </div> </td> </tr></tfoot>
</table>
</div> </section></section></body></html></body></html>
